These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 8130858

  • 1. Bromide pharmacokinetics in cystic fibrosis.
    Miller ME, Kornhauser DM.
    Arch Pediatr Adolesc Med; 1994 Mar; 148(3):266-71. PubMed ID: 8130858
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cephalexin pharmacokinetics in patients with cystic fibrosis.
    Nahata MC, Lubin AH, Visconti JA.
    Dev Pharmacol Ther; 1984 Mar; 7(4):221-8. PubMed ID: 6468223
    [Abstract] [Full Text] [Related]

  • 6. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis.
    Kearns GL, Hilman BC, Wilson JT.
    J Pediatr; 1982 Feb; 100(2):312-8. PubMed ID: 7035640
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Probenecid pharmacokinetics in cystic fibrosis.
    Weber A, de Groot R, Ramsey B, Williams-Warren J, Smith A.
    Dev Pharmacol Ther; 1991 Feb; 16(1):7-12. PubMed ID: 1879255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis.
    Moriconi N, Kraenzlin M, Müller B, Keller U, Nusbaumer CP, Stöhr S, Tamm M, Puder JJ.
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1586-90. PubMed ID: 16464949
    [Abstract] [Full Text] [Related]

  • 13. Insulin sensitivity and insulin clearance in cystic fibrosis patients with normal and diabetic glucose tolerance.
    Lanng S, Thorsteinsson B, Røder ME, Nerup J, Koch C.
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):217-23. PubMed ID: 7923827
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS, Spino M, Isles AF, Tesoro AM, Gold R, MacLeod SM.
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [Abstract] [Full Text] [Related]

  • 16. The pharmacokinetics of antibiotics in cystic fibrosis.
    Akkerman-Nijland AM, Akkerman OW, Grasmeijer F, Hagedoorn P, Frijlink HW, Rottier BL, Koppelman GH, Touw DJ.
    Expert Opin Drug Metab Toxicol; 2021 Jan; 17(1):53-68. PubMed ID: 33213220
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis.
    Wang XX, Feng MR, Nguyen H, Smith DE, Cibrik DM, Park JM.
    Eur J Clin Pharmacol; 2015 Jun; 71(6):673-679. PubMed ID: 25943384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.